Pulmonary Medicine Reference
Oxygen Therapy Devices · Expanded Technical Reference

🫧 Oxygen Therapy Devices Expanded Technical Details · Low‑Flow, High‑Flow, Home O₂ & Hyperbaric Systems

1. Classification of Oxygen Delivery Systems

Oxygen delivery devices are categorized by whether the delivered flow meets or exceeds the patient's inspiratory demand.

System TypeDefinitionFiO₂Examples
Low‑Flow (Variable Performance)Flow rate < patient's inspiratory flow → room air entrainment → FiO₂ varies with respiratory patternVariable (24‑90%)Nasal cannula, simple mask, non‑rebreather mask
High‑Flow (Fixed Performance)Flow rate ≥ patient's inspiratory flow → minimal room air entrainment → precise, stable FiO₂Fixed (24‑100%)Venturi mask, high‑flow nasal cannula (HFNC)

2. Low‑Flow Systems: Detailed Analysis

Nasal Cannula

  • Flow range: 1–6 L/min (adults). Higher flows (>4 L/min) require humidification to prevent mucosal drying.
  • FiO₂ Estimation: Each 1 L/min of O₂ flow adds approximately 3‑4% FiO₂ above 21% (room air).
    Estimated FiO₂ (%) = 21 + (Flow in L/min × 4)
    Example: 3 L/min ≈ 21 + 12 = 33% FiO₂.
  • Factors affecting actual FiO₂:
    • Respiratory rate and tidal volume: Higher minute ventilation → more room air entrainment → lower FiO₂.
    • Mouth vs. nose breathing: Mouth breathing reduces FiO₂ (less pharyngeal reservoir).
    • Peak inspiratory flow: Patients in respiratory distress may have inspiratory flows >30‑40 L/min, greatly exceeding delivered O₂ flow → low FiO₂.
  • Clinical Pearls: Best for stable patients requiring low‑moderate FiO₂. Cannot reliably deliver FiO₂ >40‑45%. At 6 L/min, actual FiO₂ may be as low as 35‑40% if tachypneic.

Simple Face Mask

  • Flow range: 5–10 L/min. Minimum flow 5 L/min to flush exhaled CO₂ from the mask and prevent rebreathing.
  • FiO₂ range: ~35–50%. FiO₂ varies with patient effort and mask fit.
  • Limitations: Uncomfortable for prolonged use, interferes with eating/drinking, risk of CO₂ rebreathing if flow <5 L/min.

Non‑Rebreather Mask (NRBM) / Reservoir Mask

  • Components: Face mask with one‑way valves on exhalation ports (prevent room air entrainment) + reservoir bag with one‑way valve (prevents exhaled gas from entering bag).
  • Flow range: 10–15 L/min. Flow must be sufficient to keep reservoir bag at least partially inflated throughout inspiration.
  • FiO₂ range: ~60–90%. Never delivers 100% FiO₂ due to mask leak and imperfect valve function.
  • Critical Setup: Ensure reservoir bag is inflated before placing on patient. If bag collapses completely during inspiration, increase flow rate.
  • Indications: Severe hypoxemia, trauma, pre‑intubation, carbon monoxide poisoning (until HBOT available).
  • Warning: Do not use in patients at risk for hypercapnia (COPD) without close monitoring — can deliver dangerously high FiO₂.

Partial Rebreather Mask

  • Similar to NRBM but no one‑way valves between mask and reservoir bag. Allows some exhaled gas (rich in O₂ from anatomic dead space) to enter bag.
  • FiO₂ ~50–60%. Rarely used clinically; NRBM preferred for high FiO₂ needs.

3. High‑Flow / Fixed‑Performance Systems

Venturi Mask (Air‑Entrainment Mask)

  • Mechanism: Uses the Bernoulli principle — high‑velocity O₂ jet passes through a narrow orifice, creating negative pressure that entrains a fixed volume of room air through side ports. Different color‑coded adapters provide specific FiO₂ (24%, 28%, 31%, 35%, 40%, 50%).
  • Total gas flow delivered = O₂ flow + entrained air flow. This total flow often exceeds patient's peak inspiratory flow, ensuring stable FiO₂.
  • Indications: Gold standard for patients with COPD and other conditions at risk for hypercapnia, where precise FiO₂ control is essential.
  • Limitations: Uncomfortable, interferes with eating, FiO₂ limited to ≤50% (higher FiO₂ requires smaller entrainment port → lower total flow → may not meet inspiratory demand).
📐 Entrainment Ratio Calculation: For a Venturi mask set to deliver 28% FiO₂, the O₂:air entrainment ratio is approximately 1:10. That means 1 L/min O₂ flow entrains 10 L/min air → total flow = 11 L/min. If a patient's peak inspiratory flow exceeds total flow, room air is entrained, and actual FiO₂ drops below the labeled value.

High‑Flow Nasal Cannula (HFNC)

Advanced Physiology HFNC delivers heated, humidified blended air‑oxygen at flows up to 60 L/min via specialized large‑bore nasal prongs. It provides multiple physiologic benefits beyond simple oxygenation.

Components of HFNC System

  • Flow generator (air‑oxygen blender) → Active heated humidifier → Heated inspiratory circuit → Large‑bore nasal cannula.
  • Flow rates: 20–60 L/min (adults). FiO₂: 0.21–1.0 (titratable).

Physiologic Mechanisms

MechanismEffectClinical Benefit
Dead Space WashoutHigh flow flushes CO₂ from upper airway (nasopharynx, oropharynx) → fresh gas in anatomic dead spaceImproves CO₂ clearance, reduces work of breathing, ↓ PaCO₂
PEEP EffectHigh flow creates positive nasopharyngeal pressure (~1 cm H₂O per 10 L/min flow with mouth closed)Alveolar recruitment, counteracts auto‑PEEP, improves oxygenation
Reduced Inspiratory ResistanceFlow meets or exceeds inspiratory demand → patient does not need to generate negative pressure to entrain airDecreased work of breathing
Optimal HumidificationHeated, humidified gas (37°C, 100% relative humidity)Preserves mucociliary function, prevents mucosal injury, improves secretion clearance

Clinical Indications for HFNC

  • Acute hypoxemic respiratory failure (pneumonia, ARDS, pulmonary edema)
  • Pre‑oxygenation before intubation (apneic oxygenation)
  • Post‑extubation support (reduces reintubation rate)
  • Do‑not‑intubate patients with hypoxemia
  • Bronchoscopy in hypoxemic patients
  • Heart failure with pulmonary edema (reduces preload and afterload)

HFNC Weaning Protocol

  • Wean FiO₂ first to ≤0.4–0.5 while maintaining SpO₂ target.
  • Once FiO₂ is low, gradually reduce flow rate (e.g., by 5–10 L/min every few hours).
  • Typical transition: HFNC → conventional nasal cannula when flow ≤20 L/min and FiO₂ ≤0.4.
⚠️ HFNC in COVID‑19 / ARDS: HFNC generates aerosols; use negative‑pressure room and appropriate PPE. In severe ARDS, monitor for delayed intubation; ROX index (SpO₂/FiO₂ ÷ RR) at 2–12 hours predicts HFNC success vs. need for intubation.

4. Home Oxygen Therapy: LTOT Criteria & Equipment

Long‑Term Oxygen Therapy (LTOT) Indications (Medicare / ATS/ERS)

  • Resting hypoxemia: PaO₂ ≤55 mmHg or SpO₂ ≤88% on room air (at rest, awake).
  • PaO₂ 56–59 mmHg or SpO₂ 89% with evidence of cor pulmonale, right heart failure, or hematocrit >55%.
  • Exercise‑induced hypoxemia: Desaturation with exertion; ambulatory oxygen improves exercise capacity.
  • Nocturnal hypoxemia: Documented on overnight oximetry; may require nocturnal oxygen.
📊 Evidence for LTOT: The Nocturnal Oxygen Therapy Trial (NOTT) and MRC trial showed that continuous oxygen (≥15‑18 hours/day) improves survival in COPD with severe resting hypoxemia. Oxygen does not improve survival in moderate hypoxemia (PaO₂ 56‑65 mmHg). (LOTT Trial).

Home Oxygen Delivery Systems

SystemMechanismAdvantagesDisadvantages
Oxygen ConcentratorRemoves nitrogen from room air via molecular sieve (zeolite) → delivers 90‑95% O₂ at 1‑10 L/minUnlimited supply, no refills, cost‑effective for homeRequires electricity, noisy, heavy (stationary), portable units have limited flow/battery
Compressed Gas CylinderO₂ stored under high pressure (2,000‑3,000 psi) in steel or aluminum tanksReliable, no power needed, high flow capabilityLimited supply (requires refill/exchange), heavy, safety concerns (projectile if valve damaged)
Liquid Oxygen SystemO₂ stored as liquid at −183°C in insulated reservoir; converts to gas for deliveryLarge volume of O₂ in small container (1 L liquid = ~860 L gas), lightweight portable units can be refilled from home reservoirExpensive, evaporates over time (~1‑2 lbs/day), requires vendor refills

Oxygen‑Conserving Devices (OCDs)

  • Purpose: Extend duration of portable O₂ supply by delivering O₂ only during inspiration.
  • Types:
    • Pulse‑Dose (Demand) Delivery: Delivers a bolus of O₂ at the beginning of inspiration. Not suitable for patients with weak inspiratory effort, mouth breathing, or high respiratory rates.
    • Reservoir Cannula: Stores O₂ during exhalation in a small reservoir; patient inhales from reservoir.
    • Transtracheal Catheter: Direct tracheal O₂ delivery via small catheter; reduces anatomic dead space, improves efficiency (requires surgical placement and meticulous care).
  • Caution: Pulse‑dose devices must be titrated to ensure adequate SpO₂ during activity and sleep; may not provide equivalent FiO₂ to continuous flow in all patients.

5. Hyperbaric Oxygen Therapy (HBOT)

Mechanism of Action

  • Patient breathes 100% O₂ at pressures >1 atmosphere absolute (ATA), typically 2–3 ATA.
  • Henry's Law: Amount of dissolved gas in liquid is proportional to partial pressure. At 3 ATA, PaO₂ reaches ~2,000 mmHg; dissolved O₂ in plasma alone can meet tissue metabolic demands (independent of hemoglobin).
  • Physiologic effects:
    • Reduces gas bubble size (Boyle's Law) — essential for decompression sickness and arterial gas embolism.
    • Enhances neutrophil oxidative killing, inhibits bacterial toxin production (clostridial myonecrosis).
    • Promotes angiogenesis and wound healing (radiation injury, chronic wounds).
    • Displaces CO from hemoglobin and cytochrome oxidase (CO poisoning).

Indications for HBOT (Undersea & Hyperbaric Medical Society)

Emergency IndicationsNon‑Emergency Indications
Arterial gas embolism
Decompression sickness ("the bends")
Severe carbon monoxide poisoning
Clostridial myonecrosis (gas gangrene)
Necrotizing soft tissue infections
Radiation tissue injury (osteoradionecrosis, soft tissue)
Compromised skin grafts / flaps
Chronic refractory osteomyelitis
Diabetic foot ulcers (Wagner grade 3+)
Idiopathic sudden sensorineural hearing loss

Contraindications & Complications

  • Absolute contraindication: Untreated pneumothorax (risk of tension pneumothorax during decompression).
  • Relative contraindications: Severe COPD (air trapping), recent thoracic surgery, uncontrolled seizures, pregnancy (except CO poisoning), claustrophobia.
  • Complications: Barotrauma (ear, sinus, lung), oxygen toxicity (CNS: seizures; pulmonary: tracheobronchitis, ↓ DLCO), transient myopia (reversible lens swelling), confinement anxiety.

6. Special Considerations in Oxygen Therapy

Humidification

  • Dry O₂ (<5% relative humidity) causes mucosal drying, impaired mucociliary clearance, nasal discomfort, and epistaxis.
  • Indications for humidification: Flows >4 L/min via nasal cannula, any flow via tracheostomy, HFNC (always heated/humidified), or patient discomfort.
  • Bubble humidifiers (unheated) provide ~30‑40% relative humidity; heated humidifiers (HFNC, ventilators) provide 100% relative humidity at body temperature.

Oxygen Toxicity

  • Pulmonary (Lorrain‑Smith effect): Prolonged exposure to FiO₂ >0.6 → tracheobronchitis, impaired mucociliary clearance, absorption atelectasis, and ultimately diffuse alveolar damage (ARDS).
  • CNS (Paul Bert effect): Hyperbaric O₂ → seizures (generally self‑limited, no long‑term sequelae).
  • Retinopathy of Prematurity (ROP): Hyperoxia in preterm infants → retinal neovascularization, retinal detachment, blindness. Strict SpO₂ targets (typically 90‑95%) in NICU.

Fire Safety

  • Oxygen is not flammable, but it vigorously supports combustion. Materials that burn in air will burn explosively in O₂‑enriched environments.
  • Safety rules: No smoking, no open flames, keep O₂ equipment ≥6‑10 feet from heat sources, avoid petroleum‑based products (Vaseline) near O₂ (use water‑based lubricants), secure cylinders to prevent tipping.

7. Quick Reference: Oxygen Device Selection

Clinical ScenarioRecommended DeviceRationale
Stable mild hypoxemia (SpO₂ 88‑92%)Nasal cannula 1‑4 L/minAdequate FiO₂, comfortable, allows eating/talking
COPD exacerbation, target SpO₂ 88‑92%Venturi mask 24‑28%Precise FiO₂, prevents hypercapnia
Moderate hypoxemia, non‑COPD (SpO₂ 85‑90%)Simple mask or nasal cannula 5‑6 L/minHigher FiO₂ than NC alone
Severe hypoxemia / pre‑intubationNon‑rebreather mask 15 L/min or HFNCMaximizes FiO₂, HFNC provides additional physiologic benefits
Acute hypoxemic respiratory failureHFNC (start 40‑60 L/min, FiO₂ 1.0)Washes out dead space, provides PEEP, reduces work of breathing
Carbon monoxide poisoningNRBM 15 L/min → HBOT if indicatedMaximizes CO elimination; HBOT for severe poisoning
Post‑extubation supportHFNC (prophylactic)Reduces reintubation rate vs. conventional O₂

FiO₂ Estimation Reference Table (Low‑Flow Systems)

DeviceFlow Rate (L/min)Approximate FiO₂
Nasal Cannula1
2
3
4
5
6
24‑25%
27‑29%
31‑33%
35‑37%
39‑41%
43‑45%
Simple Face Mask5‑6
7‑8
9‑10
35‑40%
40‑45%
45‑50%
Non‑Rebreather Mask10‑1560‑90%

Note: Actual FiO₂ varies with patient's minute ventilation and inspiratory flow.

💡 HFNC Benefits Mnemonic: "WASH PEEP"
Washes out dead space · Alveolar recruitment · Secretion clearance (humidification) · High flow meets demand · PEEP effect · Eases work of breathing · Extubation success · Pre‑oxygenation.

🫧 Oxygen Therapy Devices · Expanded Technical Reference for Medical Students and Clinicians.
Covers low‑flow and high‑flow systems, FiO₂ estimation, HFNC physiology, home oxygen equipment, and hyperbaric oxygen therapy.